The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

The World Health Organization is drawing up a list of reasons why the U.S. should remain in the WHO for its own good, two ...

Ozempic and Wegovy are among the 15 drugs added to Medicare's list of medications that will be negotiated for lower prices. This is part of an effort to lower prescription drug prices for Medicare ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

We recently compiled a list of the 10 Best Stocks to Invest in According to Billionaire Cliff Asness. In this article, we are ...

Few companies embody the term 'pharma giant' as much as Pfizer ... On their way out the door, the Biden administration has dropped the list of the next 15 drugs to be negotiated by Medicare.

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 27,497.06 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...